Chiron Investment Management, LLC Corcept Therapeutics Inc Transaction History

Chiron Investment Management, LLC

  • $281 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$21.1 - $27.46 $21,648 - $28,173
1,026 Added 75.78%
2,380 $59,000
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $33,606 - $44,519
1,354 New
1,354 $43,000
Q4 2022

Feb 13, 2023
BUY
$19.95 - $29.96 $32,219 - $48,385
1,615 Added 40.81%
5,572 $113,000
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $97,737 - $115,227
3,957 New
3,957 $101,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Chiron Investment Management, LLC Portfolio

Follow Chiron Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email